Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. An optimal therapy for the treatment of pneumonia caused by drug-resistant Acinetobacter baumannii remains unclear. ... in healthy adults demonstrated that a 4-hour infusion of SUL 3 g every 8 hours would be an appropriate dosage regimen of SUL ... Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia: a review ...

  2. 10 Νοε 2020 · We aimed to review relevant randomized controlled trials to assess the relative clinical effects of antibiotic treatment of patients with community-acquired pneumonia (CAP). Methods: In this meta-analysis, we identified relevant studies from PubMed, Cochrane, and Embase using appropriate keywords.

  3. 16 Αυγ 2023 · Most outpatients with mild community-acquired pneumonia can be treated empirically without diagnostic testing for bacteria. However, testing for SARS-CoV-2 and influenza should be considered....

  4. 15 Ιουλ 2020 · The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) recently updated their recommendations on the diagnosis and treatment of community-acquired...

  5. 6 Δεκ 2021 · In this article, we review current knowledge on the management of pneumonia in critically ill patients, including CAP and HAP, focusing on epidemiology, microbial etiology, pathogenesis, treatment, and prevention.

  6. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions.

  7. Objectives To find the optimal treatment duration with antibiotics for community-acquired pneumonia (CAP) in adults. Design Systematic review and duration-effect meta-analysis. Data sources MEDLINE, Embase and CENTRAL through 25 August 2021.